nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—BCHE—diaphragm—sarcoma	0.0594	0.292	CbGeAlD
Aclidinium—CHRM3—muscle of abdomen—sarcoma	0.0584	0.287	CbGeAlD
Aclidinium—Cardiac failure—Thiotepa—sarcoma	0.0211	0.0265	CcSEcCtD
Aclidinium—Urinary retention—Thiotepa—sarcoma	0.0196	0.0246	CcSEcCtD
Aclidinium—Cardiac failure—Mitoxantrone—sarcoma	0.0183	0.0229	CcSEcCtD
Aclidinium—Urinary retention—Vincristine—sarcoma	0.0174	0.0218	CcSEcCtD
Aclidinium—Infestation NOS—Thiotepa—sarcoma	0.0159	0.02	CcSEcCtD
Aclidinium—Infestation—Thiotepa—sarcoma	0.0159	0.02	CcSEcCtD
Aclidinium—Cardiac failure—Etoposide—sarcoma	0.0152	0.0191	CcSEcCtD
Aclidinium—Urinary tract disorder—Thiotepa—sarcoma	0.0141	0.0177	CcSEcCtD
Aclidinium—Urethral disorder—Thiotepa—sarcoma	0.014	0.0176	CcSEcCtD
Aclidinium—Dysphonia—Epirubicin—sarcoma	0.0139	0.0175	CcSEcCtD
Aclidinium—Eye disorder—Thiotepa—sarcoma	0.0133	0.0167	CcSEcCtD
Aclidinium—Sinusitis—Mitoxantrone—sarcoma	0.0129	0.0162	CcSEcCtD
Aclidinium—Dysphonia—Doxorubicin—sarcoma	0.0129	0.0162	CcSEcCtD
Aclidinium—Mediastinal disorder—Thiotepa—sarcoma	0.0129	0.0161	CcSEcCtD
Aclidinium—Urinary tract disorder—Vincristine—sarcoma	0.0125	0.0157	CcSEcCtD
Aclidinium—Urethral disorder—Vincristine—sarcoma	0.0124	0.0156	CcSEcCtD
Aclidinium—Rhinitis—Mitoxantrone—sarcoma	0.0124	0.0155	CcSEcCtD
Aclidinium—CHRM5—skin of body—sarcoma	0.0118	0.0581	CbGeAlD
Aclidinium—Vision blurred—Thiotepa—sarcoma	0.0117	0.0147	CcSEcCtD
Aclidinium—Infestation NOS—Etoposide—sarcoma	0.0114	0.0143	CcSEcCtD
Aclidinium—Infestation—Etoposide—sarcoma	0.0114	0.0143	CcSEcCtD
Aclidinium—Mediastinal disorder—Vincristine—sarcoma	0.0114	0.0143	CcSEcCtD
Aclidinium—Cough—Thiotepa—sarcoma	0.0108	0.0136	CcSEcCtD
Aclidinium—Urinary tract disorder—Etoposide—sarcoma	0.0101	0.0127	CcSEcCtD
Aclidinium—Vision blurred—Mitoxantrone—sarcoma	0.0101	0.0127	CcSEcCtD
Aclidinium—Infection—Thiotepa—sarcoma	0.0101	0.0126	CcSEcCtD
Aclidinium—Urethral disorder—Etoposide—sarcoma	0.01	0.0126	CcSEcCtD
Aclidinium—Infection—Dactinomycin—sarcoma	0.01	0.0125	CcSEcCtD
Aclidinium—Nervous system disorder—Thiotepa—sarcoma	0.00994	0.0125	CcSEcCtD
Aclidinium—Tachycardia—Thiotepa—sarcoma	0.0099	0.0124	CcSEcCtD
Aclidinium—Eye disorder—Etoposide—sarcoma	0.00958	0.012	CcSEcCtD
Aclidinium—Diabetes mellitus—Epirubicin—sarcoma	0.00955	0.012	CcSEcCtD
Aclidinium—CHRM4—testis—sarcoma	0.00953	0.0469	CbGeAlD
Aclidinium—Cough—Mitoxantrone—sarcoma	0.00936	0.0118	CcSEcCtD
Aclidinium—Mediastinal disorder—Etoposide—sarcoma	0.00924	0.0116	CcSEcCtD
Aclidinium—Infection—Vincristine—sarcoma	0.00893	0.0112	CcSEcCtD
Aclidinium—Diabetes mellitus—Doxorubicin—sarcoma	0.00884	0.0111	CcSEcCtD
Aclidinium—Nervous system disorder—Vincristine—sarcoma	0.00882	0.0111	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Thiotepa—sarcoma	0.00875	0.011	CcSEcCtD
Aclidinium—Infection—Mitoxantrone—sarcoma	0.0087	0.0109	CcSEcCtD
Aclidinium—Tachycardia—Mitoxantrone—sarcoma	0.00855	0.0107	CcSEcCtD
Aclidinium—Cardiac failure—Epirubicin—sarcoma	0.00851	0.0107	CcSEcCtD
Aclidinium—Osteoarthritis—Epirubicin—sarcoma	0.00831	0.0104	CcSEcCtD
Aclidinium—Cardiac failure—Doxorubicin—sarcoma	0.00788	0.00989	CcSEcCtD
Aclidinium—Cough—Etoposide—sarcoma	0.00779	0.00977	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Vincristine—sarcoma	0.00776	0.00974	CcSEcCtD
Aclidinium—Osteoarthritis—Doxorubicin—sarcoma	0.00769	0.00965	CcSEcCtD
Aclidinium—Nasopharyngitis—Epirubicin—sarcoma	0.00743	0.00932	CcSEcCtD
Aclidinium—Infection—Etoposide—sarcoma	0.00724	0.00908	CcSEcCtD
Aclidinium—BCHE—myometrium—sarcoma	0.00722	0.0355	CbGeAlD
Aclidinium—Tachycardia—Etoposide—sarcoma	0.00711	0.00892	CcSEcCtD
Aclidinium—Diarrhoea—Thiotepa—sarcoma	0.00694	0.00871	CcSEcCtD
Aclidinium—Diarrhoea—Dactinomycin—sarcoma	0.00689	0.00864	CcSEcCtD
Aclidinium—Nasopharyngitis—Doxorubicin—sarcoma	0.00687	0.00863	CcSEcCtD
Aclidinium—CHRM3—smooth muscle tissue—sarcoma	0.00669	0.0329	CbGeAlD
Aclidinium—BCHE—seminal vesicle—sarcoma	0.00653	0.0321	CbGeAlD
Aclidinium—Vomiting—Thiotepa—sarcoma	0.00645	0.00809	CcSEcCtD
Aclidinium—Infestation—Epirubicin—sarcoma	0.0064	0.00803	CcSEcCtD
Aclidinium—Infestation NOS—Epirubicin—sarcoma	0.0064	0.00803	CcSEcCtD
Aclidinium—Vomiting—Dactinomycin—sarcoma	0.0064	0.00803	CcSEcCtD
Aclidinium—Headache—Thiotepa—sarcoma	0.00635	0.00797	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Etoposide—sarcoma	0.00629	0.00789	CcSEcCtD
Aclidinium—BCHE—hematopoietic system—sarcoma	0.0062	0.0305	CbGeAlD
Aclidinium—Diarrhoea—Vincristine—sarcoma	0.00615	0.00772	CcSEcCtD
Aclidinium—Sinusitis—Epirubicin—sarcoma	0.00601	0.00754	CcSEcCtD
Aclidinium—Diarrhoea—Mitoxantrone—sarcoma	0.00599	0.00752	CcSEcCtD
Aclidinium—Infestation NOS—Doxorubicin—sarcoma	0.00592	0.00743	CcSEcCtD
Aclidinium—Infestation—Doxorubicin—sarcoma	0.00592	0.00743	CcSEcCtD
Aclidinium—Rhinitis—Epirubicin—sarcoma	0.00576	0.00723	CcSEcCtD
Aclidinium—Vomiting—Vincristine—sarcoma	0.00572	0.00718	CcSEcCtD
Aclidinium—Urinary tract disorder—Epirubicin—sarcoma	0.00568	0.00712	CcSEcCtD
Aclidinium—Urethral disorder—Epirubicin—sarcoma	0.00563	0.00707	CcSEcCtD
Aclidinium—Headache—Vincristine—sarcoma	0.00563	0.00707	CcSEcCtD
Aclidinium—Vomiting—Mitoxantrone—sarcoma	0.00557	0.00699	CcSEcCtD
Aclidinium—Sinusitis—Doxorubicin—sarcoma	0.00556	0.00697	CcSEcCtD
Aclidinium—Headache—Mitoxantrone—sarcoma	0.00549	0.00689	CcSEcCtD
Aclidinium—BCHE—smooth muscle tissue—sarcoma	0.00546	0.0269	CbGeAlD
Aclidinium—BCHE—skin of body—sarcoma	0.00539	0.0265	CbGeAlD
Aclidinium—Eye disorder—Epirubicin—sarcoma	0.00537	0.00674	CcSEcCtD
Aclidinium—Rhinitis—Doxorubicin—sarcoma	0.00533	0.00669	CcSEcCtD
Aclidinium—Urinary tract disorder—Doxorubicin—sarcoma	0.00525	0.00659	CcSEcCtD
Aclidinium—Urethral disorder—Doxorubicin—sarcoma	0.00521	0.00654	CcSEcCtD
Aclidinium—Mediastinal disorder—Epirubicin—sarcoma	0.00518	0.0065	CcSEcCtD
Aclidinium—Diarrhoea—Etoposide—sarcoma	0.00498	0.00626	CcSEcCtD
Aclidinium—Eye disorder—Doxorubicin—sarcoma	0.00497	0.00624	CcSEcCtD
Aclidinium—Mediastinal disorder—Doxorubicin—sarcoma	0.00479	0.00601	CcSEcCtD
Aclidinium—Vision blurred—Epirubicin—sarcoma	0.00471	0.00592	CcSEcCtD
Aclidinium—BCHE—cardiac atrium—sarcoma	0.00471	0.0232	CbGeAlD
Aclidinium—BCHE—uterus—sarcoma	0.00469	0.0231	CbGeAlD
Aclidinium—Vomiting—Etoposide—sarcoma	0.00463	0.00581	CcSEcCtD
Aclidinium—Headache—Etoposide—sarcoma	0.00456	0.00573	CcSEcCtD
Aclidinium—Cough—Epirubicin—sarcoma	0.00437	0.00548	CcSEcCtD
Aclidinium—Vision blurred—Doxorubicin—sarcoma	0.00436	0.00548	CcSEcCtD
Aclidinium—Dry mouth—Epirubicin—sarcoma	0.00417	0.00523	CcSEcCtD
Aclidinium—CHRM3—testis—sarcoma	0.00417	0.0205	CbGeAlD
Aclidinium—Infection—Epirubicin—sarcoma	0.00406	0.00509	CcSEcCtD
Aclidinium—Cough—Doxorubicin—sarcoma	0.00404	0.00507	CcSEcCtD
Aclidinium—Nervous system disorder—Epirubicin—sarcoma	0.004	0.00503	CcSEcCtD
Aclidinium—Tachycardia—Epirubicin—sarcoma	0.00398	0.005	CcSEcCtD
Aclidinium—BCHE—bone marrow—sarcoma	0.00398	0.0196	CbGeAlD
Aclidinium—Dry mouth—Doxorubicin—sarcoma	0.00385	0.00484	CcSEcCtD
Aclidinium—Infection—Doxorubicin—sarcoma	0.00375	0.00471	CcSEcCtD
Aclidinium—Nervous system disorder—Doxorubicin—sarcoma	0.0037	0.00465	CcSEcCtD
Aclidinium—Tachycardia—Doxorubicin—sarcoma	0.00369	0.00463	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Epirubicin—sarcoma	0.00352	0.00442	CcSEcCtD
Aclidinium—BCHE—testis—sarcoma	0.0034	0.0167	CbGeAlD
Aclidinium—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00326	0.00409	CcSEcCtD
Aclidinium—BCHE—liver—sarcoma	0.00321	0.0158	CbGeAlD
Aclidinium—Diarrhoea—Epirubicin—sarcoma	0.00279	0.00351	CcSEcCtD
Aclidinium—Vomiting—Epirubicin—sarcoma	0.0026	0.00326	CcSEcCtD
Aclidinium—Diarrhoea—Doxorubicin—sarcoma	0.00258	0.00324	CcSEcCtD
Aclidinium—Headache—Epirubicin—sarcoma	0.00256	0.00321	CcSEcCtD
Aclidinium—BCHE—lymph node—sarcoma	0.00246	0.0121	CbGeAlD
Aclidinium—Vomiting—Doxorubicin—sarcoma	0.0024	0.00301	CcSEcCtD
Aclidinium—Headache—Doxorubicin—sarcoma	0.00237	0.00297	CcSEcCtD
